Spatial Learning Requires mGlu5 Signalling in the Dorsal Hippocampus

被引:0
|
作者
Shawn Zheng Kai Tan
Despina E. Ganella
Alec Lindsay Ward Dick
Jhodie R. Duncan
Emma Ong-Palsson
Ross A. D. Bathgate
Jee Hyun Kim
Andrew J. Lawrence
机构
[1] Florey Institute of Neuroscience and Mental Health,Behavioural Neuroscience Division
[2] University of Melbourne,Florey Department of Neuroscience and Mental Health
[3] University of Melbourne,Department of Anatomy and Neuroscience
[4] University of Melbourne,Department of Biochemistry and Molecular Biology
来源
Neurochemical Research | 2015年 / 40卷
关键词
Hippocampus; mGlu5; Spatial learning;
D O I
暂无
中图分类号
学科分类号
摘要
We examined the role of hippocampal metabotropic glutamate receptor 5 (mGlu5) in spatial learning and memory. Although it has been shown that mGlu5 signalling is required for certain forms of learning and memory, its role in spatial learning is unclear since studies using pharmacological or knockout mice models provide inconsistent findings. Additionally, the location in the brain where mGlu5 signalling may modulate such learning is yet to be precisely delineated. We stereotaxically injected rAAV-Cre into the dorsal hippocampus of mGlu5loxP/loxP mice to knockdown mGlu5 in that region. We show for the first time that knockdown of mGlu5 in the dorsal hippocampus is sufficient to impair spatial learning in Morris Water Maze. Locomotor activity and memory retrieval were unaffected by the mGlu5 knockdown. Taken together, these findings support a key role for dorsal hippocampal mGlu5 signalling in spatial learning.
引用
收藏
页码:1303 / 1310
页数:7
相关论文
共 50 条
  • [31] mGlu5 Receptors and Extinction of Drug-Seeking
    Lawrence, Andrew J.
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 34 - 34
  • [32] Heteroarylcyclohexylamides as mGlu5 Receptor Negative Allosteric Modulators
    Li, G.
    April, M.
    Zhou, H.
    Pu, X.
    Uberti, M. A.
    Brodbeck, R. M.
    Cajina, M.
    Chandrasena, G.
    Doller, D.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 35 - 36
  • [33] Identification and characterization of novel mGlu5 receptor antagonists
    Glatthar, R.
    Vranesic, I.
    Spanka, C.
    Orain, D.
    Troxler, T.
    Desrayaud, S.
    Fendt, M.
    Gentsch, C.
    NEUROPHARMACOLOGY, 2008, 55 (04) : 599 - 599
  • [34] Exploring the Activation Mechanism of the mGlu5 Transmembrane Domain
    Lans, Isaias
    Diaz, Oscar
    Dalton, James A. R.
    Giraldo, Jesus
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [35] Mechanisms underlying the efficacy of exercise as an intervention for cocaine relapse: a focus on mGlu5 in the dorsal medial prefrontal cortex
    Jean M. Abel
    Tanseli Nesil
    Anousheh Bakhti-Suroosh
    Patrick A. Grant
    Wendy J. Lynch
    Psychopharmacology, 2019, 236 : 2155 - 2171
  • [36] Metabotropic glutamate receptor 5 (mGlu5)-positive allosteric modulators differentially induce or potentiate desensitization of mGlu5 signaling in recombinant cells and neurons
    Hellyer, Shane D.
    Albold, Sabine
    Sengmany, Kathy
    Singh, Junaid
    Leach, Katie
    Gregory, Karen J.
    JOURNAL OF NEUROCHEMISTRY, 2019, 151 (03) : 301 - 315
  • [37] Anxiolytic-like effects of mGlu 1 and mGlu5 receptor antagonists in rats
    Pietraszek, M
    Sukhanov, I
    Maciejak, P
    Szyndler, J
    Gravius, A
    Wislowska, A
    Plaznik, A
    Bespalov, AY
    Danysz, W
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 514 (01) : 25 - 34
  • [38] PET IMAGING OF MGLU5 DURING ALCOHOL ABSTINENCE
    Hillmer, A. T.
    Angarita, G. A.
    Scheinost, D.
    Esterlis, I.
    Nabulsi, N.
    Ropchan, J.
    Huang, Y. Y.
    Krystal, J. H.
    Carson, R. E.
    O'Malley, S. S.
    Cosgrove, K. P.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 113A - 113A
  • [39] Mutations of the Shank Genes and Alterations of mGlu5 Signaling
    Verpelli, C.
    Vicidomini, C.
    Orellana, D. I.
    Sala, C.
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 61 - 61
  • [40] Translational Studies of mGlu5 NAMs for the Treatment of Pain
    Gereau, R. W.
    Montana, M. C.
    Kolber, B. J.
    Crock, L. W.
    Cavallone, L. F.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 24 - 24